Largest ever Parkinson’s research trial is starting now
Date
News
Date
Research shows it’s possible to identify Parkinson’s based on compounds found on the surface of skin. The findings offer hope that the condition could be diagnosed through a simple swab test.
Date
We’re investing up to £1.2m into pioneering research in partnership with the University of Sheffield, which aims to develop a drug to protect dopamine-producing brain cells.
Date
In 2020, coronavirus (COVID-19) brought normal life to a standstill. But the Parkinson’s community showed its resilience as people found innovative ways to support each other.
Date
The earlier groundbreaking clinical trial proved inconclusive. So we’re launching a new company tasked with planning a possible new trial.
Date
The broadcasting legend will front a new 6-part jazz series, which will also highlight the work of Parkinson’s UK.
Date
New research has advanced our understanding of a protein called alpha-synuclein, which is believed to play a central role in damaging brain cells in Parkinson’s.
Date
As Steve Ford prepares to step down, Shān brings extensive leadership experience from across the charity sector to Parkinson’s UK.
Date
Scientists in the UK have uncovered evidence that simple vision tests can predict who will develop Parkinson's dementia. And the evidence shows that a loss of wiring in the brain may be the cause.
Date
We’ve partnered with Alzheimer’s Society and University College London Hospitals (UCLH) Biomedical Research Centre. Together, we’ve developed a new resource to help lab-based researchers with patient and public involvement (PPI).
Date
Parkinson's didn't stop for coronavirus, and neither did we. Here are the three things we’re most proud of this year, and how you can get involved in 2021.